The Nasal Spray Platform Technology is an advanced drug delivery
system that administers medication directly into the nasal cavity
for rapid and effective absorption. This route is gaining
attention for its high mucosal permeability and suitability for a
wide range of therapeutics.
Daewoong Pharmaceutical is focusing on enhancing drug stability
and delivery efficiency through innovative formulation design and
the development of new administration routes. The company aims to
become the No.1 player in nasal drug delivery formulation
technology through collaborations with global experts and open
innovation.
Distinguishing Points
Proprietary Nasal Spray Devices and Evaluation TechnologyThrough joint research initiatives, Daewoong has developed its
own nasal spray devices. It has also established a Technique
Valuation System (TVS) that enables precise spray modeling by
evaluating key parameters such as spray angle, dispersion area,
and particle size.
Absorption-Enhancing TechnologyLeveraging a
platform based on absorption enhancers, Daewoong significantly
improves the bioavailability of drugs and is developing innovative
delivery technologies that enhance therapeutic efficacy.
Open Collaboration Daewoong has built a
dedicated GMP-certified manufacturing site for nasal spray
products and is expanding its network of partnerships through CDMO
and CMO collaborations.
Versatile Nasal Spray Product Development Daewoong is developing a diverse portfolio of nasal spray
products to meet various clinical needs. This includes multi-dose
systems, single- and dual-dose precision sprays, and devices with
built-in dose-counting mechanisms.